GENERIC NAME OF THE MEDICINAL PRODUCT
A. Lamivudine+Nevirapine+Stavudine Tablets IP 150mg+200mg+30mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A) Lamivudine+Nevirapine+Stavudine Tablets IP
Each uncoated tablet contains:
Lamivudine IP………………………….150mg
Nevirapine IP…………………………….200mg
Stavudine IP………………………………30mg
Excipients……………………………….….q.s
Each uncoated tablet contains:
Lamivudine IP………………………….150mg
Nevirapine IP…………………………….200mg
Stavudine IP………………………………30mg
Excipients……………………………….….q.s
THERAPEUTIC INDICATIONS:
This medication is a combination of three antiviral medicines. They work by preventing HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablets to be swallowed as a whole, and not to be chewed or crushed.
Dispense in a tight, light-resistant container, with a child-resistant closure (as required).
SCHEDULE H PRESCRIPTION DRUG- WARNING: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablets to be swallowed as a whole, and not to be chewed or crushed.
Dispense in a tight, light-resistant container, with a child-resistant closure (as required).
SCHEDULE H PRESCRIPTION DRUG- WARNING: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the physician.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the physician.
Lamivudine+Nevirapine+Stavudine Tablets IP 150mg+200mg+30mg Technical specification:
| Product Name: | Lamivudine+Nevirapine+Stavudine Tablets IP |
| Brand Name: | Generic |
| Strength: | 150mg+200mg+30mg |
| Dosage Form: | Tablets (uncoated) |
| Route of Administration: | Via Oral Route |
| Packing: | 60 Tablets in Bottle |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antiviral |
| Indication: | This medication is a combination of three antiviral medicines. They work by preventing HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood. |
| Storage: | Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
Lamivudine+Nevirapine+Stavudine Tablets IP 150mg+200mg+30mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Lamivudine+Nevirapine+Stavudine Tablets IP
Each uncoated tablet contains:
Lamivudine IP…………………………..150mg
Nevirapine IP…………………………….200mg
Stavudine IP………………………………30mg
Excipients……………………………….….q.s
THERAPEUTIC INDICATIONS:
- This medication is a combination of three antiviral medicines. They work by preventing HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.
CAUTION & SCHEDULE:
- CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablets to be swallowed as a whole, and not to be chewed or crushed.
Dispense in a tight, light-resistant container, with a child-resistant closure (as required).
- SCHEDULE H PRESCRIPTION DRUG- WARNING: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
STORAGE & DOSAGE:
- Storage: Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture.
- Dosage: As directed by the physician.
